BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1372592)

  • 1. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells.
    Tandon N; Morgan BP; Weetman AP
    Immunology; 1992 Feb; 75(2):372-7. PubMed ID: 1372592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.
    Tandon N; Yan SL; Morgan BP; Weetman AP
    Immunology; 1994 Apr; 81(4):643-7. PubMed ID: 7518800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of complement regulatory proteins on thyroid epithelial cells of Graves' disease.
    Nakai H; Hirakawa S; Hayakawa N; Amano T; Ota Z
    Acta Med Okayama; 1992 Oct; 46(5):323-30. PubMed ID: 1279944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells.
    Tandon N; Makgoba MW; Gahmberg CG; Weetman AP
    Clin Immunol Immunopathol; 1992 Jul; 64(1):30-5. PubMed ID: 1376653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins.
    Rooney IA; Davies A; Morgan BP
    Immunology; 1992 Mar; 75(3):499-506. PubMed ID: 1374057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid follicular cell function after non-lethal complement membrane attack.
    Weetman AP; Freeman M; Morgan BP
    Clin Exp Immunol; 1990 Oct; 82(1):69-74. PubMed ID: 2170066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells.
    Weetman AP; Tandon N; Morgan BP
    Lancet; 1992 Sep; 340(8820):633-6. PubMed ID: 1381035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
    Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
    J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease.
    Weetman AP; Cohen SB; Oleesky DA; Morgan BP
    Clin Exp Immunol; 1989 Jul; 77(1):25-30. PubMed ID: 2766576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.
    Rooney IA; Morgan BP
    Immunology; 1990 Nov; 71(3):308-11. PubMed ID: 1702747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells.
    Weetman AP; Cohen S; Makgoba MW; Borysiewicz LK
    J Endocrinol; 1989 Jul; 122(1):185-91. PubMed ID: 2671237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of the complement-regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with IL-1 beta, endotoxin, IFN-gamma, or phorbol ester.
    Schieren G; Janssen O; Hänsch GM
    J Immunol; 1992 May; 148(10):3183-8. PubMed ID: 1578143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.
    Zheng RQ; Abney ER; Chu CQ; Field M; Maini RN; Lamb JR; Feldmann M
    Immunology; 1992 Mar; 75(3):456-62. PubMed ID: 1572693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease].
    Zhang H; Li D; Ouyang A
    Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
    Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
    Hopf U; Fiek T; Grün R; Zuschneid W
    J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.
    Bogner U; Schleusener H; Wall JR
    J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigenic relation between thyroid peroxidase and the microsomal antigen implicated in auto-immune diseases of the thyroid].
    Czarnocka B; Ruf J; Ferrand M; Carayon P
    C R Acad Sci III; 1985; 300(15):577-80. PubMed ID: 2410085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.